MOTS-C, SS-31, and SLU-PP-332 – Peptides for Peak Mitochondrial Health
Mitochondria are cellular powerhouses that control everything: energy levels, recovery speed, cognitive clarity, and even how quickly the body ages. For a long time, the only tools for supporting mitochondrial function were considered to be physical activity, calorie restriction, and coenzyme Q10. But in recent years, the picture has changed. Mitochondria peptides have entered the scene – compounds that directly affect the energy processes of cells at the molecular level.
Three compounds are considered to be the main ones in this category:
- MOTS-C peptide is an endogenous peptide encoded by mitochondrial DNA, which is being studied in the context of metabolic regulation and physical performance.
- SS-31 peptide (elamipretide) – a synthetic tetrapeptide that targets the inner mitochondrial membrane and is being studied in the context of cardioprotection and cellular resilience.
- SLU-PP-332 peptide is an agonist of ERR (estrogen-related receptors) that is called the “exercise molecule” for its ability to activate metabolic pathways normally triggered by physical activity.
Each of these peptides approaches the task from a different angle. But they share a common goal: to keep mitochondria functioning at maximum efficiency. And this is not just of theoretical interest: when you are over thirty (and especially over forty), you begin to notice that your energy levels are not what they used to be, recovery after training takes longer, and your morning coffee no longer helps with chronic fatigue. All of these sensations often have the same cause: mitochondrial dysfunction.
How MOTS-C, SS-31, and SLU-PP-332 Support Cellular Energy
To understand why these three compounds are attracting so much attention, we need to recall some basic biology. Mitochondria produce ATP – the universal energy currency of the cell – through oxidative phosphorylation. Each cell contains several hundred to several thousand mitochondria, and particularly “voracious” tissues – the heart, brain, and skeletal muscles – are literally packed with them. With age, chronic stress, lack of sleep, and unhealthy eating, this process degrades: mitochondria become damaged, their number decreases, and the electron transport chain begins to “leak,” generating more free radicals and less ATP. The result is fatigue, slow recovery, cognitive decline, and increased susceptibility to disease. Mitochondrial peptides attack this problem from different angles:
- MOTS-C activates AMPK, the cell’s “energy sensor,” triggering cascades associated with glucose utilization, fatty acid oxidation, and mitochondrial biogenesis. In essence, it mimics the metabolic signal of physical exercise.
- SS-31 works differently: it embeds itself in the inner mitochondrial membrane, stabilizing cardiolipin, a phospholipid critical to the electron transport chain.
- SLU-PP-332 activates the ERR?, ERR?, and ERR? receptors, which regulate the expression of genes involved in oxidative metabolism and mitochondrial function.
Together, these three compounds cover the main vulnerabilities of the mitochondrial apparatus. That is why peptides for energy in this category are of interest not only to scientists, but also to practitioners – biohackers, athletes, and people who want to feel less exhausted at the end of the workday.
MOTS-C Peptide – Benefits and Applications
MOTS-C peptide is the most unusual of the three. It is encoded not by nuclear DNA, but by mitochondrial DNA – specifically, the 12S rRNA gene. This makes it one of the few known “mitokines” – signaling molecules that mitochondria send to other parts of the cell and even to other tissues. The discovery of MOTS-C in 2015 by Professor Pinchas Cohen’s group at the University of Southern California caused a minor sensation in the field of metabolic biology. Essentially, MOTS-C is a message from your own mitochondria: “we need help” or “it’s time to switch metabolism.”
The key MOTS-C benefits observed in preclinical and early clinical studies are related to metabolic regulation. The peptide improves glucose utilization, increases insulin sensitivity, and stimulates fatty acid oxidation. In mouse experiments, MOTS-C administration prevented obesity development on a high-fat diet and improved physical endurance, even without additional training.
For practitioners, MOTS-C class peptides for mitochondrial health are interesting in several contexts:
- Supporting metabolism during age-related decline in activity
- Optimization of energy balance during intense exercise
- Potential protection against the metabolic consequences of chronic stress
Of particular interest is the link between MOTS-C and insulin resistance, a key problem in modern metabolic health. Preliminary data indicate that this peptide may improve glucose utilization by skeletal muscles, making it beneficial not only for athletes but also for people with sedentary lifestyles. It is not a “pill instead of running” – but a compound that can enhance the metabolic response to a healthy lifestyle.
SS-31 Peptide at a Glance
SS-31 peptide (Elamipretide) is a synthetic tetrapeptide with a unique property: it specifically binds to cardiolipin on the inner membrane of mitochondria. Cardiolipin is the “glue” that holds the electron transport chain complexes in the correct configuration. When cardiolipin oxidizes (which occurs with aging, oxidative stress, and ischemia), ATP synthesis efficiency decreases and electron leakage increases, creating a vicious cycle of damage.
SS-31 benefits center on stabilizing this membrane: reducing reactive oxygen species production, improving oxidative phosphorylation efficiency, and supporting the cell’s overall “energy capacity.”
In clinical trials, elamipretide is being investigated for heart failure and primary mitochondrial diseases, where its ability to protect mitochondrial peptide membranes from degradation could be life-saving. For biohackers and athletes, SS-31 is an interesting tool for supporting cellular energy under high and chronic stress.
SLU-PP-332 Peptide – A Next-Level Mitochondrial Booster

SLU-PP-332 peptide is the youngest of the three compounds and perhaps the most intriguing. Strictly speaking, it is not a classic peptide, but a small molecule – an agonist of ERR (estrogen-related receptors). However, the research compound market classifies it as a “peptide,” which is justified in the context of mitochondrial health: its targets are the same metabolic pathways as MOTS-C, only with a different entry point.
ERR?, ERR?, and ERR? receptors are orphan nuclear receptors that regulate the expression of genes associated with oxidative metabolism, mitochondrial biogenesis, and muscle endurance. Under normal conditions, their activation is enhanced by physical exercise. SLU-PP-332 mimics this signal pharmacologically, hence its nickname “exercise mimetic,” a training-imitating molecule.
SLU-PP-332 benefits demonstrated in preclinical experiments are impressive:
- Increased proportion of oxidative (slow) muscle fibers
- Increased endurance
- Enhanced fat metabolism
- Protection of muscles from atrophy
In studies on mice, SLU-PP-332 almost doubled the time to exhaustion during running, without any training program.
For context, achieving this result through training would require weeks of consistent work. Obviously, data from mice cannot be directly extrapolated to humans, but the scale of the effect explains why this compound has caused such a stir in the scientific community.
When combined with other mitochondria peptides – especially MOTS-C – SLU-PP-332 creates a potentially powerful synergistic effect: one activates the AMPK cascade, the other activates ERR-dependent programs. Two different “entrances” to the same energy optimization system.
Why Mitochondria Peptides Are Popular for Energy and Recovery
The boom in interest in mitochondrial peptides is no accident. It coincided with several cultural and scientific trends at once:
- First, the topic of longevity moved out of academic circles and into the mainstream. People learned that aging is largely a story of mitochondrial degradation, and they wanted to do something about it.
- Second, the post-COVID reality has exacerbated the problem of chronic fatigue: millions of people have found themselves in a situation where their “batteries won’t recharge” and have started looking for solutions.
Peptides for energy from the mitochondrial category were in the right place at the right time. They offer not stimulation (like caffeine or amphetamines), but optimization – addressing the cause of fatigue rather than its symptoms. For biohackers, this is a philosophically correct approach: don’t “whip the horse,” but “fix the engine.” And judging by how quickly these compounds are gaining an audience, the approach resonates far beyond niche communities.
The sports community has picked up on the topic for another reason: recovery. The more efficiently mitochondria work, the faster tissues regenerate after exercise, and the less oxidative damage accumulates between workouts. For serious athletes, this is the difference between progress and plateau. And for amateurs, it’s the difference between feeling like “I can train four times a week” and “I need a week to recover from one workout.”
Combining MOTS-C, SS-31, and SLU-PP-332 for Maximum Effect
The idea of combining the MOTS-C peptide, SS-31 peptide, and SLU-PP-332 peptide makes sense from a biochemical standpoint. Each compound works through a separate mechanism, and theoretically, their effects should complement rather than duplicate each other:
- MOTS-C triggers AMPK and metabolic reprogramming.
- SS-31 stabilizes membranes and protects the electron transport chain from oxidative damage.
- SLU-PP-332 activates ERR-dependent gene expression, enhancing mitochondrial biogenesis.
In practice, however, there is currently no data on the combined use of these three compounds in humans – research has focused on each of them separately. This means that combinations remain in the realm of hypotheses and individual experiments, rather than proven protocols.
Those considering this approach should start with one compound, evaluate the body’s response over several weeks, and add the next only then – this is the basic principle of responsible biohacking. There is no need to rush: mitochondrial health is a marathon, not a sprint.
How to Choose the Right Mitochondria Peptide for Your Goals

The choice between mitochondrial peptides depends on your goals. There is no universal “best” option – there is only the one that is right for your specific situation.
- Metabolic optimization and weight management – MOTS-C. Its effects on AMPK, glucose utilization, and fat oxidation make it the top choice for those working on metabolic health.
- Cell protection and cardiovascular support – SS-31. Stabilizing cardiolipin and reducing oxidative stress are its key strengths. It is especially interesting for older audiences and people with high levels of chronic stress.
- Endurance and muscle function – SLU-PP-332. Activation of ERR receptors, an increase in the proportion of oxidative fibers, and imitation of a training signal make it attractive to athletes and those seeking to support their physical performance.
Regardless of the choice, product quality remains a fundamental criterion. A peptide with unconfirmed purity turns any experiment into a lottery – you don’t know what you’re working with and can’t interpret the results. This is especially important for mitochondrial compounds, where the effects are often subjective (energy, well-being, sleep quality) and can easily be mistaken for a placebo if the product is of poor quality.
Buying MOTS-C, SS-31, and SLU-PP-332 Peptides Safely Online
The market for mitochondrial peptides is growing, and with it, the number of suppliers – from reputable to downright questionable. This is especially true for new compounds such as SLU-PP-332, where demand currently outstrips supply, and the temptation to sell “something similar” under the right name is particularly strong. How can you tell a reliable supplier apart? The principles are the same as for any research compound: public Certificates of Analysis (CoA) for each batch, confirmed purity by HPLC and mass spectrometry, and transparent storage and delivery conditions.
Grey Research Peptides offers MOTS-C peptide, SS-31 peptide, and SLU-PP-332 peptide with confirmed purity of ?99%. Each compound is synthesized using advanced methods, undergoes multi-stage quality control, and is stored under conditions that ensure the stability of the active substance. For those looking for peptides for energy and mitochondrial support, we provide not just a product, but the confidence that you are working with the stated compound.Explore our catalog and start with the peptide that best suits your goals. Mitochondrial health is one of the most promising areas in biohacking and preventive medicine, and high-quality tools for advancing this work are now more accessible than ever.
Frequently Asked Questions
What do MOTS-c, SS-31, and SLU-PP-332 have in common in mitochondrial research?
All three are studied for their effects on mitochondrial function, but through different mechanisms. MOTS-c is a mitochondrial-derived signaling peptide that activates AMPK. SS-31 is a synthetic peptide that binds cardiolipin in the inner mitochondrial membrane to stabilize cristae structure. SLU-PP-332 is a small-molecule ERR agonist studied for upregulating mitochondrial biogenesis. They represent three distinct entry points into mitochondrial biology.
How does SS-31 differ mechanistically from the other two?
SS-31 is unique because it directly targets the inner mitochondrial membrane by binding cardiolipin — a phospholipid unique to mitochondria. This binding stabilizes cristae architecture, reduces reactive oxygen species generation, and preserves ATP production. MOTS-c and SLU-PP-332 act through indirect signaling pathways rather than direct membrane interaction with the organelle itself.
What does MOTS-c research show about metabolic outcomes?
MOTS-c increases intracellular AICAR levels, which activates AMP-activated protein kinase (AMPK). Preclinical studies have documented improved glucose uptake, enhanced fatty acid oxidation, increased insulin sensitivity, and resistance to diet-induced obesity in rodent models. Circulating MOTS-c levels decline with age in both rodents and humans, making it a focus of aging-related metabolic research.
Why is SLU-PP-332 sometimes described as an exercise mimetic?
SLU-PP-332 is a pan-ERR (estrogen-related receptor) agonist studied in rodent models for effects that resemble exercise training — increased mitochondrial biogenesis, improved running endurance, and shifts in muscle fiber type composition. Unlike peptide-based compounds, it is a small molecule, which gives it different pharmacokinetic and delivery characteristics in research designs.